Dan Furstenberg

Artificial Intelligence and Machine Learning in Medicine: Hope or Hype?

Rick Berke, Rowan Chapman, Iya Khalil, Lloyd Minor, George Yancopoulos, Megan Zweig, Dan Furstenberg

Industry leaders and researchers convened to address the critical bottleneck of poor data quality in healthcare AI, noting that high-quality "big data" is essential for overcoming the limitations of existing Electronic Health Records and avoiding failures like those seen with IBM Watson. While venture capital has pivoted from high-risk clinical decision support to near-term applications in operational efficiency and medical imaging, participants advocated for long-term systemic reforms such as FDA mandates for molecular data collection and a $200 million biobank initiative to enable precise patient phenotyping. The panel concluded that bridging the gap between clinical trial success and real-world outcomes requires rigorous regulatory frameworks and collaborative investment to reduce physician burnout and improve drug development success rates.